Alpine Immune Sciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -6.79 | -100% |
| P/S |
|
16.49 | 33.58 | -50.89% |
|
|
| P/BV |
|
2.96 | 4.79 | -38.22% |
|
|
| P/FCF |
|
0 | 60.06 | -100% |
|
|
| Ev/Ebitda |
|
-21.45 | -17.26 | 24.3% |
|
|
| Ev/S |
|
15.91 | 22.49 | -29.22% |
|
|
| Ev/FCF |
|
-11.79 | 67.63 | -117.43% |
|
|
| E/P |
|
0 | 0.0168 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-74.18 | 4.5 | -1749.74% | -629.1 | -88.21% |
| ROE |
|
-9.81 | 9.39 | -204.5% |
|
|
| ROA |
|
-8.43 | 0.1519 | -5648.33% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-54.66 | -25.64 | 113.18% |
|
|
| ROCE |
|
-13.49 | 15.19 | -188.85% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.227 | -3.68 | -93.83% | -0.2227 | +1.93% |
| Nеt Debt/Ebitda |
|
0.7787 | -4.07 | -119.15% |
|
|
| Debt/Ratio |
|
0.026 | 0.199 | -86.95% |
|
|
| Debt/Equity |
|
6.2 | 1.67 | 272.13% |
|
|
| Debt/Net Income |
|
-0.308 | 10.34 | -102.98% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
3363.29 | 76.2 | 4313.77% | ||
| Growth impulse Ebitda in 5 years |
|
5.24 | 44.75 | -88.29% | ||
| Growth impulse Net Income in 5 years |
|
-24.27 | -15.36 | 58.01% | ||
| Growth impulse FCF in 5 years |
|
119.61 | -9.39 | -1373.8% | ||
| Growth impulse EPS in 5 years |
|
-72.26 | -84.03 | -14.01% |
IP Score
3.15/10
